Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Patients with Acute Coronary Syndrome associated with de novo atrial fibrillation are randomized to benefit from either a conventional therapy associating dual antiplatelet therapy (DAPT) and anticoagulant or DAPT and an implantable monitoring device with a follow-up by telecardiology
Epistemonikos ID: 705a47d00f93a8d36d86e7eb6d22faa1d22d51d1
First added on: May 07, 2024